Japanese cedar pollinosis
Conditions
Interventions
administraion standerdised Jaanese cedar extract sublingually for 2minute and then spit the extract
administraion placebo sublingually for 2minute and then spit
Sponsors
Nippon Medical School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patient with allergic rhinitis, who have specific IgE RAST (cedar pollen) score 2 in the past 2years. 2) Patient who have nasal obstruction, and typical allergic rhinitis symptoms for at least 2 years. 3) Written informed consent is required.
Exclusion criteria
Exclusion criteria: 1) Patients with disease which make objective evaluation difficult. * infection disease * nonallergic rhinitis * medicamentosa 2) Anti-allergy drug treatment within two weeks of study entry. 3) Patients who have received immunotherapy. 4) Allergic Rhinitis patients who underwent laser surgery and operation within 6 months. 5) Uncontrolled asthma patients 6) Patients who have the hypersensitivity to study drugs 7) Infectious diseases and mycosis, with no effective therapeutic drug. 8) Pregnant or lactating women and women with possibility of pregnancy. 9) Patients who were judged to be unsuitable for patient enrollment by their doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| nasal symptoms score (diary) | — |
Countries
Japan
Outcome results
None listed